Blagova O V, Nedostup A V, Kogan E A, Dzemeshkevich S L, Frolova Iu V, Sedov V P, Gagarina N V, Sulimov V A, Abugov S A, Zakliaz'minskaia E V, Donnikov A E, Kadochnikova V V, Kupriianova A G, Zaĭdenov V A, Beletskaia L V
Ter Arkh. 2011;83(9):41-8.
To study possibility of nosological diagnosis in patients with dilated cardiomyopathy (DCMP) with use of myocardial biopsy.
The trial enrolled 62 patients (23 females) with DCMP syndrome (end diastolic left ventricular size > 5.5 cm, ejection fraction < 55%). Mean age of the patients was 46.0 +/- 12.8 years. The examination included diagnosis of viral infections (Herpes virus, parvovirus B19), measurement of anticardial antibodies titer, 99Tc-MIBI single photon emission computed tomography of the myocardium, multislice computed tomography, MRT of the heart, coronarography, morphological study of the myocardium (n=20) with application of polymerase chain reaction (PCR) for H.simplex viruses of types 1, 2 and 6, herpes zoster, Epstein-Barr, cytomegalovirus, parvovirus B-19, adenoviruses. The control group (20 operated patients with valvular heart disease and coronary heart disease) was examined for viral genome in the blood and myocardium.
Complex examination of DCMP patients showed the following distribution by nosological entuities: myocarditis (n=41, 66.1%) including virus-positive (n=14), primary DCMP (n=16, 25.9%) including with non-compact myocarditis (NCM) in 3, with debute at delivery of the child--in 3. Arrhythmogenic right ventricular dysplasia combined with viral myocarditis (n=2), genetic myopathy (n=1) and Takayasu disease (n=1) combined with NCM, isolated NCM (n=1) were diagnosed in the rest cases. Morphological investigation of the myocardium was made in 20 patients: diagnosis of myocarditis and primary DCMP were made in 70% (including in 2 patients with CHD) and 20%. Detection of viral genome was 20 and 15% in the study and control group, respectively, in the myocardium--in 57.9 (test for parvovirus B19 was not made in 26%) and 65.0% (complete diagnosis). All the virus-positive patients with DCMP were diagnosed to have signs of active/borderline myocarditis. Diagnostic criteria and poor prognosis factors were defined.
The nosological diagnosis of DCMP was made in all the examinees basing on the complex of clinical, case history and device evidence. The diagnosis was morphologically verified in 33.9% patients. Treatment approaches are developed.
研究通过心肌活检对扩张型心肌病(DCMP)患者进行疾病分类诊断的可能性。
该试验纳入了62例DCMP综合征患者(23例女性)(左心室舒张末期内径>5.5 cm,射血分数<55%)。患者的平均年龄为46.0±12.8岁。检查包括病毒感染诊断(疱疹病毒、细小病毒B19)、抗心肌抗体滴度测量、心肌的99Tc-MIBI单光子发射计算机断层扫描、多层计算机断层扫描、心脏磁共振成像、冠状动脉造影、心肌形态学研究(n = 20),应用聚合酶链反应(PCR)检测1、2和6型单纯疱疹病毒、带状疱疹病毒、爱泼斯坦-巴尔病毒、巨细胞病毒、细小病毒B-19、腺病毒。对照组(20例接受手术的瓣膜性心脏病和冠心病患者)检测血液和心肌中的病毒基因组。
对DCMP患者的综合检查显示疾病分类实体的分布如下:心肌炎(n = 41,66.1%),包括病毒阳性(n = 14);原发性DCMP(n = 16,25.9%),包括3例合并非致密性心肌病(NCM),3例在分娩时起病;致心律失常性右心室发育不良合并病毒性心肌炎(n = 2)、遗传性肌病(n = 1)、高安病(n = 1)合并NCM,其余病例诊断为孤立性NCM(n = 1)。对20例患者进行了心肌形态学研究:70%诊断为心肌炎和原发性DCMP(包括2例冠心病患者),20%为原发性DCMP。研究组和对照组心肌中病毒基因组的检测率分别为20%和15%,57.9%(26%未检测细小病毒B19)和65.0%(完整诊断)。所有病毒阳性的DCMP患者均被诊断为有活动性/临界性心肌炎体征。确定了诊断标准和不良预后因素。
基于临床、病史和器械证据的综合情况,对所有受检者进行了DCMP的疾病分类诊断。33.9%的患者经形态学证实了诊断。制定了治疗方法。